Epidemiology

Epidemiology constitutes the scientific study of disease distribution, determinants, and patterns within populations, providing quantitative frameworks for understanding disease occurrence, identifying risk factors, evaluating interventions, and informing public health policies. This discipline employs diverse study designs including cohort studies, case-control studies, cross-sectional surveys, and randomised trials. Epidemiological methods generate evidence supporting causal relationships, quantifying disease burdens, and guiding resource allocation.

The biopharmaceutical industry engages with epidemiology throughout therapeutic development and commercialisation. Pre-development epidemiology studies characterise disease burden, prevalence, incidence, and unmet medical needs informing target selection. Post-marketing surveillance employs pharmacoepidemiological methods monitoring real-world safety through spontaneous reporting systems, database studies, and registries detecting rare adverse events. Comparative effectiveness research uses observational epidemiological approaches evaluating how treatments perform in diverse real-world populations. As real-world evidence grows in regulatory and payer importance, epidemiological expertise becomes increasingly valuable supporting evidence generation, regulatory strategies, and market access.